Masimo announced FDA clearance and full market release of Rad-97™ Pulse CO-Oximeter®, including configurations with blood pressure and capnography.
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Acta Paediatrica in which researchers from the Hospital ...
Masimo Corporation MASI recently announced the findings of a study published in Clinical Medicine Insights: Pediatrics, demonstrating the experience using the Masimo Rad-G Pulse Oximeter. The study ...
IRVINE, Calif., Sept. 3 Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, today announced that its Radical-7 and Rad-57 Pulse CO ...
Masimo said it received a subpoena from the Department of Justice seeking documents and information related to its Rad-G and Rad-97 pulse oximeters, including complaints about the products and the ...
Masimo SET ® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates, 1 improve CCHD screening in newborns, 2 and, when used for continuous monitoring in ...
Noting that in resource-limited environments, respiration rate (RR) measurement is often used to directly inform medical decisions for children with respiratory problems, but that manual RR counting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results